The use of a composite graft of bovine trabecular demineralized bone matrix (DBM) and perichondrium has been found a reliable method for in vivo generation of cartilage. In the present study, the mechanism whereby this commercially available matrix increases cartilage formation was investigated.
Introduction
Defects in the cartilage of nose, cricoid, ear or articular joints show limited tendency of spontaneous healing. For repair of these defects with transplants, the use of * Corresponding author. Tel.:#31 10 4087661; fax:#31 10 4367146.
autologous tissue is preferred in order to avoid immunological reactions and the risk of transmittable diseases. The amount of autologous cartilage that can be harvested is limited and the consequent donor site morbidity is high. In contrast, isolation of autologous perichondrium is relatively easy for patient and surgeon and results in minimal donor site morbidity and a low complication rate. Therefore, perichondrium has been suggested as a producer of new cartilage [1] [2] [3] [4] [5] . The amount of cartilage generated from perichondrium in vivo, however, appeared to be variable and unpredictable [1] [2] [3] . In previous research, our group has demonstrated a new experimental method using rabbits: a composite graft of trabecular demineralized bone matrix (DBM) and perichondrium can provide much more consistent results [6, 7] . Perichondrium wrapped around DBM leads to gradual replacement of the DBM by autologous cartilage tissue [6] even in the child [8] . Implanted subcutaneously in the ear or intramuscularly in the quadriceps of rabbits the grafts showed cartilage formation in 100% of the samples after 3-6 weeks [7] .
In our studies a trabecular matrix (DBM, Osteovit ) was chosen because the porosity of the matrix was considered of importance for the ingrowth of cells. The role of DBM for chondrogenesis could be 'physical', by acting as a spacer for cell ingrowth or 'chemical', induced by growth factors which are suggested to be present in the matrix. The aim of this study was to investigate the role of the trabecular DBM in this process in more detail. We first studied the time course of the cartilage generating process in vivo with special focus on cellular responses to DBM. The chondrogenic capacities of the material itself were evaluated by implantation of the material without perichondrium. In the literature, cortical DBM is often described to induce chondro-and osteogenesis and is demonstrated to contain growth factors [9, 10] . We studied the presence of growth factors in our matrix using immunohistochemistry. Since TGF , BMP and IGF are recognized as factors present in DBM [9, 10] and are described to induce chondrogenesis [11] [12] [13] [14] [15] , they were added to perichondrium in culture to study the effects on chondrogenesis. In a further attempt to define the conditions that permit chondrogenesis in the composite of perichondrium and DBM, we mimicked the in vivo procedure in culture. Perichondrium was wrapped around DBM and cultured in vitro and the effects of addition of macrophages and blood was evaluated on histology.
Materials and methods
The various experimental conditions are outlined in Table 1 .
In vivo studies
Twelve female New Zealand White rabbits were used (weighing 1200-1800 g, age 6-12 weeks). Anaesthesia was given with xylazine-hydrochloride (Rompun, Bayer, Leverkusen, Germany) 10 mg kg\ body weight and ketamine-hydrochloride (Ketalin, Apharma, Arnhem, Netherlands) 50 mg kg\ body weight via intramuscular injection. The operation site was shaved and disinfected with 70% ethanol. After making a rectangular incision (approximately 2;6 cm) at the concave side of the ear, the skin was elevated and the perichondrium dissected from the underlying cartilage. A rectangular piece of trabecular DBM (Osteovit , Braun Gmbh, Melsungen, Germany) measuring approximately 4;4;8 mm was soaked in blood. This block was wrapped in perichondrium such that the perichondrial side dissected off the cartilage (the cambium layer) faced the DBM surface, and left in situ in the ear for 3 days, 1, 2 or 3 weeks. Furthermore, DBM was implanted subcutaneously without perichondrial envelope and left in the ear for 1, 3 or 6 weeks.
In vitro studies
Ear perichondrium was obtained from 15 young female New Zealand White rabbits (age 6-12 weeks) as described above. After washing with physiological saline containing gentamicin (50 g ml\) and fungizone (0.5 g ml\) to remove blood and contaminants, the perichondrium was cut into pieces of about 2 mm using scalpels. Four explants were cultured per well of a 24-wells plate in DMEM/Ham's F12 (1 : 1) medium (Life Technologies, Breda, The Netherlands) containing 10% heat-inactivated FCS, 25 g ml\ L-ascorbic acid (Sigma), 50 g ml\ gentamicin and 0.5 g ml\ fungizone. The explants were cultured for 3 weeks and medium was changed three times per week. Results were evaluated using histological analysis.
The in vitro studies attempted to mimic step by step the in vivo situation (Fig. 1) . As possible chondrogenic factors, growth factors were added to cultures of perichondrium or perichondrium was combined with DBM. Addition of macrophages, important for resorption of the matrix in-vivo, was studied next. Finally, DBM was 'colonized' by cells in vivo before it was enwrapped with perichondrium and subsequently cultured in vitro.
To test the effects of growth factors, rhTGF-2 (Sandoz, Switzerland), rhOP-1 (Creative Biomolecules, Hopkinton, Massachusetts) or rhIGF-1 (BoehringerMannheim, Almere, The Netherlands) were added to ear perichondrium cultured in medium with 10% FCS. TGF-2 and OP-1 were added in a concentration of 10 ng ml\ continuously or as a pulse treatment in a concentration of 100 ng ml\ for the first 2 days only. IGF-1 was added in a concentration of 10 ng ml\ continuously. Furthermore, the effect of a combination of 10 ng ml\ IGF-1 and 10 ng ml\ TGF-2 added for 3 weeks was tested under serum-free conditions in DMEM/Ham's F12 medium with 0.1% BSA and 25 g ml\ L-ascorbic acid. All concentrations were based on data from literature [11] [12] [13] [14] [15] [16] [17] .
DBM was cut into pieces of 2-6 mm and a combination of DBM and perichondrium were tested under the following conditions: (1) Perichondrium explants excised at a size of approximately 2;7 mm and wrapped around the DBM matrix, with the layer which faced the cartilage towards the DBM, and cultured for 3 weeks. (2) DBM seeded with macrophages before perichondrium was wrapped around it. Autologous macrophages were isolated together with the perichondrium by washing the peritoneal cavity of the rabbit with PBS immediately after killing the animal. The peritoneal cavity was opened with a small incision and 0.3-0.5 l PBS was introduced in the cavity. After closing the incision, the abdomen was gently massaged to allow solvation of peritoneal macrophages in PBS. Then, as much PBS (with cells) as possible was retained from the cavity through a disposable needle (1.1 mm;40 mm). The cells were separated from the solution by centrifugation. Cytospins stained with mAb CD68 showed that'95% of the isolated cells were macrophages. After washing, the cells were seeded in DBM in a density of 5;10 cells ml\ to allow a large amount of macrophages to adhere to and degrade the DBM. After incubation for at least 30 min, the DBM-macrophage composite was enwrapped in perichondrium. (3) DBM (with or without macrophages) soaked in autologous blood and cultured in vitro. (4) DBM pre-incubated in vivo by implantation of 10;10;3 mm DBM subcutaneously in the ear for 6 days. After harvesting, the DBM was cultured with or without perichondrial envelope.
Histology

Presence of growth factors in DBM
Cryosections of pure DBM were prepared. Sections of human demineralized bone were used as control. To evaluate the effectiveness of the demineralization procedure, staining according to Goldner was used. Immunohistochemical staining for growth factors IGF1 (using a rabbit polyclonal, GroPep, Adelaide, Australia), TGF 2 and 3 (using rabbit polyclonals 1 : 50, Santa Cruz Biotechnology, CA) was performed after formalin fixation in the absence and presence of saponin. A signal was made visible using 3-amino-9-ethylcarbazole (AEC) as substrate.
In vivo cartilage formation
To study the chondrogenic potential of DBM, implants without perichondrium were harvested after 1, 3 or 6 weeks. Implants with perichondrium were harvested after 3 days, 1, 2 and 3 weeks (n"6 for each time point) to assess chondrogenesis and cellular response to DBM. All specimens were cut into two equal parts; one part was fixed in 4% phosphate-buffered formalin, decalcified with 10% EDTA and embedded in paraffin. Serial sections were cut (7 m) and stained with Alcian Blue 8GX (Sigma, St Louis, MO) to study cartilage matrix formation. The other part was frozen in liquid nitrogen and stored at !80°C until cryosections (6 m) were made. Immunohistochemistry was performed on these sections to characterize the matrix generated and to evaluate the cell-mediated resorption of DBM. Sections were fixed in acetone. For collagen staining the sections were treated with hyaluronidase (Sigma, St Louis, MO), for chondroitin sulfate staining the sections were treated with chondroitinase ABC (Sigma). The sections were incubated overnight at 4°C with mAb against collagen type II (CIICI; 1 : 100; Developmental Studies Hybridoma Bank), pro-collagen type I (M38; 1 : 1000; Developmental Studies Hybridoma Bank) or chondroitin 6-sulfate (3B3; 1 : 1000; ICN Biomedicals, Costa Mesa, CA). To study host tissue reactions against DBM, sections were incubated for 2 h at room temperature with mAbs against macrophages using CD68 (1 : 50; Behring, Marburg, Germany) and neutrophils using -lactoferrine (1 : 25; Pharmingen, San Diego, CA). After incubation with primary antibodies, sections were treated with goat-anti-mouse biotin, followed by streptavidin alkaline phosphatase (Supersensitive, Biogenics, Clinipath, Duiven, The Netherlands). Alkaline phosphatase activity was demonstrated using a New Fuchsin substrate (Chroma, Kongen, Germany). This resulted in a red coloured signal. Endogenous alkaline phosphatase activity was inhibited with levamisol (Sigma). Sections were counterstained with Gill's haematoxylin and embedded in gelatin-glycerin.
In vitro cartilage formation
After three weeks in vitro, the explants were harvested, fixed in 4% phosphate buffered formalin and embedded in paraffin. Sections of 6 m thickness were cut and four sections, spaced 60 m apart, were mounted on one slide, stained with Alcian Blue 8GX and counterstained with Nuclear Fast Red.
The incidence of new cartilage formation in the explants was scored. A Fisher's exact test was used for statistical analysis. The percentage of the area stained with Alcian Blue was quantified using image analysis using Videoplan software (Kontron, Zeiss, The Netherlands) using two high quality sections at least 200 m apart, for each sample. Since small pieces of cartilage could be included when perichondrium was dissected (accounting for up to 10% of the tissue area), distinction was made between pre-existing and newly formed cartilage based on the intensity of Alcian Blue staining and the morphology of the cells. The amount of newly formed cartilage was expressed as a percentage of the total area corrected for pre-existing cartilage and calculated as follows:
Area newly formed cartilage/ (Total area!Area pre-existing cartilage).
The median and range were calculated and Kruskall Wallis one-way ANOVA and rank sum test were used for statistical analysis. A P value(0.05 was considered statistically significant.
Finally, immunohistochemical stainings for collagen type II was performed on the paraffin sections. Sections were pretreated with pronase type XIV (Sigma) to regain antigenicity which was lost due to formalin fixation, and with hyaluronidase (Sigma) to obtain better antibody penetration. Incubation with monoclonal antibody II-II6B3 (Developmental Studies Hybridoma Bank) was followed by incubation with a second antibody conjugated with alkaline phosphatase. Alkaline phosphatase activity was demonstrated with a New Fuchsin substrate, resulting in a red color.
Results
In vivo
DBM without perichondrium
Without perichondrial cover, no cartilage or bone was ever formed subcutaneously in the DBM. After three weeks, the DBM was completely resorbed in three out of six samples. After 6 weeks complete resorption of DBM had occurred in all samples.
DBM with perichondrium
Cartilage formation. Three and seven days after implantation, no cartilage formation was present in the DBM. The perichondrium stained positive for (pro)collagen type I and chondroitin sulfate. In addition, the inner layer of the perichondrium stained positive for collagen type II. After 7 days, cells and loose fibrous tissue was found between the trabeculae of the DBM. Many of the cells stained positive for chondroitin sulfate and occasionally for (pro)collagen type I. After 2 weeks, islets of cartilage were found in the pores of the DBM (Fig. 2) . These islets showed positive staining for Alcian Blue, chondroitin sulfate and collagen type II. After 3 weeks the islets of cartilage had fused to a massive cartilaginous structure (Fig. 3) . Occasionally, cysts and bloodvessels were found in the cartilage.
Resorption of DBM. After 3 days the perichondrium was markedly thickened. Macrophages were present in the perichondrium tissue and some had also invaded the graft and were attached to DBM. The first 2 weeks after implantation, the number of macrophages in perichondrium as well as DBM gradually increased (Fig. 4) . After 2 weeks, the DBM was fragmented and after 3 weeks no signs of DBM were observed any more and the amount of macrophages was strongly reduced. Some macrophages were still present where islets of cartilage were not completely fused. Only a few neutrophils could be detected during the whole period.
In vitro
Both the incidence and the amount of cartilage formed in cultures with 10% FCS (controls) of auricular perichondrium appeared to be variable. Cartilage formation varied between none or a few chondrocytes to a maximum of half of the explant area (Fig. 5) . To investigate the role of DBM in chondrogenesis in vivo, the presence of growth factors in demineralized bovine trabecular bone matrix was tested. Immunohistochemistry demonstrated a faint staining for IGF1 and TGF 2, 3. The absolute amounts could not be determined this way, but staining was generally much lower than in human trabecular bone which had been demineralized by acetic acid and was used as a positive control.
Addition of the recombinant growth factors IGF1, TGF 2 or OP1 to perichondrium cultures in the presence of 10% FCS, did not improve incidence nor amount of cartilage formation (Table 2 ). Since we could not demonstrate a difference between continuous or pulsed addition of growth factors, these two conditions were combined in the results. Serum free cultures to which a combination of IGF1 and TGF 2 was added for three weeks did not result in stimulation of chondrogenesis.
The use of DBM in perichondrium cultures did not change the incidence nor the amount of cartilage formation after 3 weeks (Table 2) . Besides induction of cartilage in the explants, colonization of the DBM by cells was observed (Fig 6) . These cells had a round shape and a halo of matrix that stained positively with Alcian Blue. Immunohistochemistry for collagen type II was not feasible on these sections because the DBM did not remain attached to the slide surface during the staining procedure. The variability in the results with DBM were thought to be partly due to variable adhesion of perichondrium tissue to DBM. Attempts were made to advance the adhesion by soaking the DBM in autologous blood before it was wrapped in the perichondrium. This, however, did not influence incidence nor amount of cartilage formation.
In vivo studies have demonstrated that resorption of DBM is performed mainly by macrophages. In vitro macrophages seeded in DBM did not result in visible resorption of the DBM in 3 weeks. Also it did not increase cartilage formation. Combination of blood and macrophages could not mimic the in vivo situation. Since adhesion and activity of the macrophages was questionable, DBM was implanted subcutaneously in the ear for 6 days before culturing with or without perichondrium in vitro. As described in the in vivo experiments, after 6 days subcutaneous implantation, macrophages, mesenchymal cells and some fibrous tissue were present in the DBM but at this point cartilage formation was still absent. Then this DBM was cultured for 3 weeks with or without a perichondrial envelope, and cartilage formation could be observed in the DBM, however, it was independent of the presence or absence of a perichondrial envelope. Visible resorption of DBM after 6 days in vivo implantation was not observed after 3 weeks of culture. Table 2 Incidence of chondrogenesis and amount of cartilage formation in vitro in perichondrium after 3 weeks of culture under various conditions. The amount of cartilage formation was quantified using image analysis in the samples where chondrogenesis was present and is presented as % of the total area of the explant. No statistically significant differences were found 
Discussion
In the literature cortical DBM has been demonstrated to contain growth factors which are held responsible for the chondro-and osteogenic potential of this matrix [9, 10] . The trabecular bovine DBM we used in this study, showed only a faint staining for growth factors. Although in earlier studies addition of growth factors in vitro was demonstrated to induce chondrogenesis in periost [11] [12] [13] [14] [15] [16] , we could not confirm this for perichondrium; the addition of IGF1, TGF 2 or OP1 in vitro did not improve chondrogenesis. The difference between perichondrium and periost or the variability in composition of the serum, might explain this discrepancy in results. Yaeger et al. [17] showed that addition of IGF-1 and TGF-2, to cultures in serum-free medium could induce redifferentiation of human articular chondrocytes which had lost their phenotype by culturing in monolayer. Even this combination of IGF-1 and TGF-2 however, did not stimulate cartilage formation from rabbit ear perichondrium.
So this study does not provide evidence for a role of growth factors from the DBM for chondrogenesis. The physical properties of trabecular DBM may be of more importance. Although the present study showed that neither the incidence nor the amount of cartilage generated in vitro was stimulated by the use of DBM, colonization of the DBM by cells could be observed. These cells survived in culture and even had a round shape and produced an Alcian Blue positive matrix, indicating viable cartilage-like cells. This suggests that DBM acts more as a scavenger for chondrogenic cells.
In vivo, resorption of DBM seems to be performed mainly by macrophages. Peritoneal macrophages have been demonstrated to manifest bone resorption [18] . Murine peritoneal macrophages in culture could absorb 40-50% of small bone particles in two days. In the present study, peritoneal macrophages were isolated, seeded in DBM and cultured together with perichondrium in vitro. Resorption of DBM was not seen macroscopically and contrary to the in vivo situation, DBM was still present after 3 weeks culture. Holtrop et al. [19] suggested that interaction of two cell types is needed for the resorption of bone fragments: one cell type inducing pre-digestion of the matrix with enzymes, and subsequently the macrophages will be able to phagocytize the debris. So probably, macrophages alone are not able to digest such large parts of DBM and addition of enzymes in vitro might be needed to optimize the action of macrophages. Landesman and Reddi [20] reported that the chondro-osteogenic potential of DBM is initially enhanced after implantation in vivo and at its highest point the first 5-7 days in vivo. Therefore, we implanted DBM in vivo for 6 days to obtain colonization with cells and a possible pre-digestion of the DBM, before culturing with perichondrium in vitro for 3 weeks. This combined in vivo/in vitro procedure, however, did not result in visible better resorption of the DBM nor did it increase chondrogenesis.
As another important factor in the in vivo process, the presence of clotted blood in contact with perichondrium is described to be necessary for cartilage formation [21] . Clotted blood consists of many platelets which contain growth factors like PDGF and TGF . Cells of the perichondrium are described to grow in the blood clot and form cartilage [22] . However, neither addition of autologous blood nor addition of blood in combination with peritoneal macrophages to our cultures resulted in any stimulation of chondrogenesis.
DBM by itself (without perichondrium) demonstrated no cartilage formation after 3-6 weeks of subcutaneous implantation in vivo. However, culturing in vitro after 6 days of subcutaneous implantation in vivo, chondrogenesis was found in one out of five samples. This indicates that cartilage generation in DBM without perichondrium in principle is possible. Chondrogenic cells were scavenged by the DBM and these cells could originate from the skin [23, 24] . Subcutaneous implantation of DBM without perichondrium for longer periods (3-6 weeks) never generated cartilage. The reason might be the early resorption of the matrix before cartilage is formed. It could be concluded that because of the fast resorption, pure trabecular bovine DBM is insufficient for cartilage production. Perichondrium is a prerequisite for fast delivery of large amounts of chondrogenic cells. Other matrices have been described in combination with perichondrium [25] [26] [27] . When a matrix of collagen, hydroxyapatite or polyglycolic acid was used, increased cartilage formation could be found, however, cartilage did not or minimally invade the biomaterial pores, but mainly lined the biomaterial [25] [26] [27] . This again suggests that fast resorption of DBM compared to these other materials might be an important factor in the process of cartilage graft formation.
In vivo, the use of a composite graft of perichondrium and DBM has shown to be a reliable method to generate new cartilage [6, 7] . Such cartilage formation could not be mimicked in vitro by addition of IGF1, TGF 2. OP1, DBM, macrophages or blood. It is suggested that this trabecular DBM has few chondrogenesis inducing qualities but functions mostly as a spacer for cell ingrowth. The generation of new cartilage by the proper cells migrating into the 'spacer' together with an optimal period for resorption of the biomaterial makes DBM an excellent matrix for chondrogenesis in vivo.
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